The Federal Trade Commission has reached a landmark settlement with Express Scripts, banning practices that favored high-priced drugs for bigger rebates and requiring lower-cost options be included in ...
A St. Louis-based wealth management firm with $400 million under management is now part of a southeastern U.S. financial ...
Preview this article 1 min The dispute centers on prescription drug claims between 2020 and 2022. Charter alleges the ...
Empty prescription bottles sit in a container at the Kaiserslautern Military Community Center Satellite Pharmacy at Ramstein Air Base, Germany, Aug. 1, 2023. (Airman Trevor Calvert/U.S. Air Force) If ...
JOHNSTOWN, Pa. (WTAJ) — Thousands of patients are still separated from a community pharmacy chain in Cambria, Somerset and Westmoreland counties after a 2025 decision by a global health company left ...
CHARLESTON, WV (WVNS) – The West Virginia Independent Pharmacy Association praised West Virginia Offices of the Insurance Commissioner for holding Express Scripts (ESI) accountable. A press release ...
Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. Today, Bernstein Litowitz Berger & Grossmann LLP (BLB&G) ...
On February 4, 2026, Express Scripts agreed to a settlement with the Federal Trade Commission (FTC) in the agency’s administrative case against the nation’s three largest pharmacy benefit managers ...
Federal regulators announced a settlement Wednesday with Express Scripts to change how the company handles prescription drug pricing. The agreement aims to lower out-of-pocket costs for patients who ...
The Federal Trade Commission has agreed to what it called a “landmark” settlement with Express Scripts, allowing the company to bow out of the agency’s lawsuit against major pharmacy benefit managers ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.